Trial Profile
A Multicenter Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control and Beyond: Comparison of Two Treatment Strategies
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Nifedipine (Primary) ; Telmisartan (Primary)
- Indications Essential hypertension
- Focus Biomarker; Therapeutic Use
- Acronyms TALENT
- Sponsors Bayer
- 15 Jun 2019 This trial has been completed in Spain, according to European Clinical Trials Database.
- 14 Jun 2012 Additional trial location identified as reported by ClinicalTrials.gov.
- 01 Sep 2010 Results presented at the ESC Congress 2010: Annual Congress of the European Society of Cardiology